跳至主要内容
临床试验/CTRI/2024/07/070696
CTRI/2024/07/070696尚未招募不适用

A comparative study to evaluate the efficacy and safety of rosuvastatin or in combination of rosuvastatin with fenofibrate in patients with dyslipidemia at tertiary care centre.

Dr Shivam Yadav1 个研究点 分布在 1 个国家目标入组 262 人开始时间: 2024年7月26日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
262
试验地点
1
主要终点
Quality of life

研究概览

简要总结

A Prospective randomized parallel group interventional study to compare efficacy and safety of Rosuvastatin alone or in combination with Fenofibrates in patients with Dyslipidemia.

研究设计

研究类型
Interventional

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Either gender aged 18 to 70 years .
  • Patients giving written informed consent will be taken.
  • Hypertensive patients.

排除标准

  • Patient not willing to participate in the study.
  • Active liver disease.
  • Preexisting gallbladder disease.
  • Type 1 diabetes mellitus.
  • Thyroid dysfunction.
  • Type 2 diabetes mellitus.
  • Any malignancies.

结局指标

主要结局

Quality of life

时间窗: Baseline, 2 months, 3 months

次要结局

  • Adverse drug reaction(At 2nd and 3rd month)

研究者

发起方
Dr Shivam Yadav
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Shivam Yadav

Baba Raghav Das Medical College, Gorakhpur

研究点 (1)

Loading locations...

相似试验